List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for the given year is not complete until April of the following year. Annual Reports data is a snapshot of agency reported information for that year and hence might look different from the live data in the Awards Information charts.

  1. Dual Formulation of Atropine and Scopolamine with Enhanced Stability

    SBC: Nano Terra, Inc.            Topic: CBD181005

    The standard US military treatment for nerve agent exposure is application of up to three autoinjectors, each containing atropine sulfate and2-pralidoxime, to counteract symptoms of nerve agent intoxication and restore acetylcholinesterase activity. This treatment increases survivalrates after nerve agent exposure, however, seizures resulting from nerve agent poisoning are a common symptom that ca ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  3. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications

    SBC: GENECAPTURE            Topic: CBD15C001

    GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...

    STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
  4. MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: Bodkin Design & Engineering, LLC            Topic: CBD171002

    We propose a snapshot mode hyperspectral imager based on the patented micro machine optical element array.This compact device will provide staring hyperspectral imagery without scanning.Operation in the LWIR will permit identification of chemical warfare agents, and toxic industrial chemicals. Its compact size will permit integration into handheld, vehicle borne or drone mounted instruments.

    SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  5. Additive Manufacture of Respiratory Protection

    SBC: AKITA INNOVATIONS LLC            Topic: CBD181001

    In the proposed SBIR project Akita Innovations and Adaptive 3D will develop feedstock materials and methods for the additive manufacture of soft elastomers that exhibit resistance to the permeation of chemical agents.The goal of the effort is to produce a fully functional Air Purifying Respirator (APR) and to demonstrate advantages of additive manufacturing to provide innovations such as custom si ...

    SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  6. Dermal Medical Countermeasures for Chemical Weapons Exposure

    SBC: Nano Terra, Inc.            Topic: CBD161003

    Chemical warfare agents (CWAs), such as nerve agents and mustard agents, pose serious threats to our warfighters and civilians. Current formulations of dermal medical countermeasures to CWAs can be absorbed through the skin causing systemic toxicities to the patients. These formulations are limited by the FDA for use only in small area of intact skin. This severely restricts the usefulness of thes ...

    SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
  7. Dermal Medical Countermeasures for Chemical Weapons Exposure

    SBC: Nano Terra, Inc.            Topic: CBD161003

    Chemical warfare agents (CWAs), such as nerve agents and mustard agents, pose serious threats to our warfighters and civilians. Current formulations of dermal medical countermeasures to CWAs can be absorbed through the skin causing systemic toxicities to the patients. These formulations are limited by the FDA for use only in small area of intact skin, which severely restricts the usefulness of the ...

    SBIR Phase I 2017 Department of DefenseOffice for Chemical and Biological Defense
  8. Smartphone Application for Mask Sizing and Projecting Quantitative Fit

    SBC: Technology Solutions Experts, Inc.            Topic: CBD161005

    Identifying the correct size of a full facepiece respirator for an individual requires a significant degree of skill. Furthermore, the fit assessment procedure is time consuming due to the series of tasks required to calculate the fit factor, a measure of the quality of fit. The Chemical and Biological Defense (CBD) program needs a quicker, less manually intensive, and more reliable method to sele ...

    SBIR Phase II 2017 Department of DefenseOffice for Chemical and Biological Defense
  9. Automated Visual Anthropometry for Three-dimensional Assessment of Respirators (AVATAR)

    SBC: Charles River Analytics, Inc.            Topic: CBD161005

    Military respirator masks provide the Warfighter with life critical protection against chemical, biological, radiological, and nuclear (CBRN)threats. To ensure the safety, comfort, and effectiveness of the American Warfighter, it is essential that every Warfighter be assigned arespirator that is properly sized and fitted. However, current methods for sizing and fitting respirators depend on manual ...

    SBIR Phase II 2017 Department of DefenseOffice for Chemical and Biological Defense
  10. Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes

    SBC: IXPRESSGENES, INC.            Topic: CBD152004

    This project is a unique metagenomic evaluation of under-studied extremophilic microbiome natural products (NPs), with the goal of discovering novel antibiotic biowarfare agent (BWA) countermeasures. A metagenomic biosynthetic gene cluster library from extremophilic sources was created, sequenced, analyzed, and exploited to produce several broad-spectrum antibiotic extracts during the Phase I effo ...

    SBIR Phase II 2017 Department of DefenseOffice for Chemical and Biological Defense

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government